123 related articles for article (PubMed ID: 26394130)
1. Identification and validation of argininosuccinate synthase as a candidate urinary biomarker for major depressive disorder.
Wu D; Peng Y; Zhou J; Yang YT; Rao CL; Bai SJ; Zhou XY; Chen J; Liao L; Liang ZH; Yang DY; Xie P
Clin Chim Acta; 2015 Dec; 451(Pt B):142-8. PubMed ID: 26394130
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
4. Urinary peptidomics identifies potential biomarkers for major depressive disorder.
Wang Y; Chen J; Chen L; Zheng P; Xu HB; Lu J; Zhong J; Lei Y; Zhou C; Ma Q; Li Y; Xie P
Psychiatry Res; 2014 Jun; 217(1-2):25-33. PubMed ID: 24661976
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
7. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in major depressive disorder: the role of mass spectrometry.
Woods AG; Iosifescu DV; Darie CC
Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
[TBL] [Abstract][Full Text] [Related]
9. Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.
Song YR; Wu B; Yang YT; Chen J; Zhang LJ; Zhang ZW; Shi HY; Huang CL; Pan JX; Xie P
Braz J Med Biol Res; 2015 Nov; 48(11):973-82. PubMed ID: 26375446
[TBL] [Abstract][Full Text] [Related]
10. Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones.
Wijaya CS; Lee JJZ; Husain SF; Ho CSH; McIntyre RS; Tam WW; Ho RCM
Int J Environ Res Public Health; 2018 Apr; 15(5):. PubMed ID: 29701669
[No Abstract] [Full Text] [Related]
11. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
12. Differential urinary metabolites related with the severity of major depressive disorder.
Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
14. Protein Biomarkers in Major Depressive Disorder: An Update.
Woods AG; Wormwood KL; Iosifescu DV; Murrough J; Darie CC
Adv Exp Med Biol; 2019; 1140():585-600. PubMed ID: 31347073
[TBL] [Abstract][Full Text] [Related]
15. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
16. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
[TBL] [Abstract][Full Text] [Related]
17. Age-specific urinary metabolite signatures and functions in patients with major depressive disorder.
Chen JJ; Xie J; Li WW; Bai SJ; Wang W; Zheng P; Xie P
Aging (Albany NY); 2019 Sep; 11(17):6626-6637. PubMed ID: 31493765
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
19. Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers.
van Buel EM; Meddens MJM; Arnoldussen EA; van den Heuvel ER; Bohlmeijer WC; den Boer JA; Muller Kobold A; Boonman-de Winter LJM; van Rumpt D; Timmers LFJ; Veerman MFA; Kamphuis JS; Gladkevich AV; Schoevers RA; Luiten PGM; Eisel ULM; Bosker FJ; Klein HC
J Psychosom Res; 2019 Oct; 125():109796. PubMed ID: 31470255
[TBL] [Abstract][Full Text] [Related]
20. MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder.
Bilello JA; Thurmond LM; Smith KM; Pi B; Rubin R; Wright SM; Taub F; Henry ME; Shelton RC; Papakostas GI
J Clin Psychiatry; 2015 Feb; 76(2):e199-206. PubMed ID: 25742207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
